prostate cancer

Interview

Dr Schweizer Talks Concordance of DDR Mutations in Paired Primary, Metastatic Prostate Cancer Samples

06/15/2021

Michael Schweizer, MD, Seattle Cancer Care Alliance, discusses a prostate cancer study that was presented at the 2021 ASCO Annual Meeting.

Michael Schweizer, MD, Seattle...

06/15/2021

Oncology

Videos

Abiraterone vs Docetaxel for De Novo Prostate Cancer in Real-World and Trial Settings

03/18/2021

Daniel Geynisman, MD, discusses results from a study which compared real-world survival among men with de novo metastatic prostate cancer treated with abiraterone acetate or docetaxel and compared these outcomes to those seen in clinical...

Daniel Geynisman, MD, discusses...

03/18/2021

Journal of Clinical Pathways

Videos

Higher Hospital Competition Associated With Improved Quality of Prostate Cancer Care

03/18/2021

Journal of Clinical Pathways

Videos

Real-World Treatment Patterns, Survival Outcomes in Metastatic Castration-Sensitive Prostate Cancer

02/25/2021

Stephen Freedland, MD, discusses study results exploring real-world evidence on survival outcomes among men with metastatic castration-resistant prostate cancer who initiated ADT or ADT combined with anti-androgens, docetaxel, or abiraterone.

Stephen Freedland, MD, discusses...

02/25/2021

Journal of Clinical Pathways